Discontinued — last reported Q4 '24
Business Segments · Assets assumed
CarelonRx — Assets assumed
Elevance Health CarelonRx — Assets assumed decreased by 7.5% to $1.59B in Q4 2024 compared to the prior quarter. This decline may warrant attention — for this metric, higher values are generally preferred.
Analysis
StatementSegment
CategoryCapital Allocation
SignalHigher is better
VolatilityModerate
First reportedQ4 2023
Last reportedQ4 2024
Rolls up toNet assets acquired
How to read this metric
An increase indicates active expansion of the segment's resource base, while a decrease suggests a period of consolidation or divestiture.
Detailed definition
Represents the total value of assets acquired by the CarelonRx segment through business combinations or asset purchase a...
Peer comparison
Similar to 'Assets Acquired' or 'Purchase Price Allocation' in other pharmacy benefit management or healthcare services segments.
Metric ID:
elv_segment_carelonrx_assets_assumedHistorical Data
2 periods
| Q4 '23 | Q4 '24 | |
|---|---|---|
| Value | $1.72B | $1.59B |
| QoQ Change | — | -7.5% |
| YoY Change | — | -7.5% |
Range$1.59B – $1.72B
Avg YoY Growth-7.5%
Median YoY Growth-7.5%
Similar Metrics at Other Companies
Frequently Asked Questions
- What is Elevance Health's carelonrx — assets assumed?
- Elevance Health (ELV) reported carelonrx — assets assumed of $1.59B in Q4 2024.
- What does carelonrx — assets assumed mean?
- The total value of assets brought into the pharmacy services segment through acquisitions.